Good MorningEquity investors got a healthy dose of reality on Friday when Apple announced it was closing stores in some hard-hit stats. Economic reopenings in states like Florida and Arizona have resulted in record new COVID cases sparking the companies decision. A total of eleven stores including those in North Carolina and South Carolina are part of the closing and more could follow in the coming days.
The news from Apple highlights a growing fear, the fear that COVID will cause another round of economic shutdown in the U.S. The S&P 500 responded by reversing gains and moving lower by roughly 1.0%. The takeaways are that however dire Friday’s news may seem, the S&P 500 still closed up for the week and poised for gains in the weeks to come. An increase in the number of COVID cases won’t hold the market back so long as the economic data is improving.
Featured: A letter from Shannon Stansberry (Ad) 
|
Markets | |
DraftKings (NASDAQ:DKNG), the world's top daily fantasy sports platform, has had little problem navigating the coronavirus pandemic. In fact, its thriving. But with American professional sports benched since early spring, how can this be?
At the onset of the COVID-19 outbreak, the stock's early 2... Read the Full Story |
|
From Our Partners | | The SpaceX IPO wasn't the big trade - according to Larry Benedict, founder of The Opportunistic Trader, it was the trigger. Benedict, who delivered a 279% return on cash in 2025 across a 20-year winning streak, says the listing launched what he calls the 'Final Phase of Elon's Master Plan.'
He's identified one specific ticker - not SpaceX, Tesla, or any Elon-affiliated company - that he believes could see billions in inflows as this phase unfolds. He calls it his trade of the year. | | Watch the video now to get the ticker name and full trade details |
|
Markets | | Beating The Estimates, And The Outlook Is Good
Smith & Wesson (SWBI) just reported a blow-out quarter, literally, and has the stock positioned for longer-term gains. The company's name was recently changed from American Outdoor Brands to Smith & Wesson Brands is the same great firearms comp... Read the Full Story |
|
Markets | | Spotify (NYSE: SPOT) surged more than 14% to all-time highs as it announced two more big podcast deals. This time, the company signed exclusive deals with Warner Brothers and Kim Kardashian West. These follow Spotify’s exclusive deal for Joe Rogan a few weeks ago, which sent shares up more tha... Read the Full Story |
|
From Our Partners | | Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. | | Watch Marc Chaikin's free presentation and get his full buy-and-sell list today |
|
Markets | |
When consumers are asked the question, Coke or Pepsi, it’s a matter of taste. But tastes are starting to change? It’s no surprise that carbonated beverages are starting to fall out of favor. Consumers are becoming more mindful of what they put into their body. And that’s meant th... Read the Full Story |
|
Markets | |
Whenever a new IPO hits the market, you can typically expect a volatile first few months of trading. This was true for Peloton Interactive (NASDAQ:PTON), a company that provides a unique and interactive fitness platform. However, after Peloton’s stock price stabilized after taking a beating ... Read the Full Story |
|
From Our Partners | | Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | | Discover the gold income fund before the next payout date |
|
Markets | |
Shares of Beyond Meat (NASDAQ:BYND) are up nearly 7% in mid-day trading. This continues a trend that has been ongoing in 2020. BYND stock has more than doubled since the beginning of the year despite seeing its share price decline by over 50% at the onset of the Covid-19 pandemic.
Why is BYND Sto... Read the Full Story |
|
Markets | | Something For The Market To Like
ESG issues, environment/social/governance, are becoming more and more important to today’s investors. Gone are the days of robber-barons, unsustainable ecological exploitation, and slave-like working conditions. In their place is a new breed of CEO, company, a... Read the Full Story |
|
Markets | | The Unseen Consequences Of COVID-19
The COVID-19 pandemic struck fast and furiously, it shut down our economy, forced us to live apart from others, and retreat into the isolated world of “home”. During this time a number of trends have emerged, trend that are already producing profits f... Read the Full Story |
|
Markets | |
Johnson & Johnson (NYSE:JNJ) stock has been volatile for the last several years, and 2020 has been no exception. But as more clarity develops surrounding the novel coronavirus, the blue-chip company is beginning to show exactly why it’s a solid investment.
Johnson & Johnson is posit... Read the Full Story |
|
Markets | |
It’s been easy to overlook eBay (NASDAQ: EBAY) over the past several years as Amazon (NASDAQ: AMZN)has taken over the e-commerce space. It has, at times, been a rocky road for Amazon’s less-glamorous competitor.
But on June 4th, eBay raised its Q2 guidance and added to the all-time hi... Read the Full Story |
|
The Early Bird Stock Of The Day Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer and castration-resistant prostate cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also developing MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; MCLA-145, which is in phase 1 clinical trials for the treatment of solid tumors; MCLA-129, which is in phase 1/2 clinical trials for the treatment of patients with advanced non-small cell lung cancer and other solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat relapsed/refractory T cell lymphoma. In addition, it has collaboration agreement with Betta Pharmaceuticals Co. Ltd for the research and development of stage bispecific antibody candidates include MCLA-129; collaboration with Incyte Corporation for the development of MCLA-145; and collaboration with Gilead Sciences, Inc. to discover novel antibody-based trispecific T-cell engagers. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands. | | View Today's Stock Pick |
|
